Azelaprag

Azelaprag
Identifiers
  • (2S,3R)-N-[4-(2,6-dimethoxyphenyl)-5-(5-methyl-3-pyridinyl)-1,2,4-triazol-3-yl]-3-(5-methylpyrimidin-2-yl)butane-2-sulfonamide
CAS Number
PubChem CID
UNII
Chemical and physical data
FormulaC25H29N7O4S
Molar mass523.61 g·mol−1
3D model (JSmol)
  • CC1=CC(=CN=C1)C2=NN=C(N2C3=C(C=CC=C3OC)OC)NS(=O)(=O)[C@@H](C)[C@H](C)C4=NC=C(C=N4)C
  • InChI=1S/C25H29N7O4S/c1-15-10-19(14-26-11-15)24-29-30-25(32(24)22-20(35-5)8-7-9-21(22)36-6)31-37(33,34)18(4)17(3)23-27-12-16(2)13-28-23/h7-14,17-18H,1-6H3,(H,30,31)/t17-,18-/m0/s1
  • Key:DOMQFIFVDIAOOT-ROUUACIJSA-N

Azelaprag (original Amgen development code AMG 986, subsequently licensed to BioAge Labs and renamed BGE-105) is a drug which is a selective, small-molecule agonist for the apelin receptor. It was originally developed as a potential treatment for heart failure and has subsequently been investigated for other applications such as obesity and muscle wasting in elderly or bed-bound patients.[1][2][3]

See also

References

  1. ^ Ason B, Chen Y, Guo Q, Hoagland KM, Chui RW, Fielden M, et al. (April 2020). "Cardiovascular response to small-molecule APJ activation". JCI Insight. 5 (8) e132898. doi:10.1172/jci.insight.132898. PMC 7205427. PMID 32208384.
  2. ^ Hellawell J, Abbasi S, Trivedi A, Tsirtsonis K, Kaufman A (October 2020). "Safety, tolerability, pharmacokinetics, and pharmacodynamics of AMG 986, a novel small molecule apelin receptor agonist, in healthy subjects and heart failure patients". Journal of Cardiac Failure. 26 (10): S68. doi:10.1016/j.cardfail.2020.09.200.
  3. ^ Pi Z, Johnson JA, Meng W, Phillips M, Schumacher WA, Bostwick JS, et al. (November 2021). "Identification of 6-Hydroxypyrimidin-4(1H)-one-3-carboxamides as Potent and Orally Active APJ Receptor Agonists". ACS Medicinal Chemistry Letters. 12 (11): 1766–1772. doi:10.1021/acsmedchemlett.1c00385. PMC 8591725. PMID 34795866.
Stub icon

This pharmacology-related article is a stub. You can help Wikipedia by adding missing information.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.